Here are relevant reports on : human-capital-management-hcm-market
-
Global Albumin Market, by Product (Human Serum Albumin, Bovine Albumin, Recombinant Serum Albumin) by Application (Therapeutic, Drug Delivery, Culture Media, Vaccine Ingredient) by Region - Forecast to 2022
The global albumin market is projected to grow at a CAGR of around 6% during the forecast period (2017-2022). Factors such as the high demand of albumin in R&D activities, rising non-therapeutic application of albumin, development of plant based albumin, rising production of immunoglobulins, and rise in plasma collection are driving the market. However, the stringent regulations, limited reimbursement, and irrational uses and adverse effects associated with albumin are the factors restraining the growth of this market.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Electrical SCADA Market by Architecture (Hardware, Software, and Services), Component (Master Terminal unit, Remote Terminal unit, Human Machine Interface), Application (Generation, Transmission, and Distribution), and Region - Global Forecast to 2022
The electrical SCADA market is expected to grow from an estimated USD 2.29 Billion in 2017 to USD 3.29 Billion by 2022, at a CAGR of 7.48%, during the forecast period. This growth can be attributed to factors such as increased investments in electrical networks and government initiatives toward the adoption of industrial automation. To enable an in-depth understanding of the competitive landscape, the report includes the profiles of some of the top players in the electrical SCADA market. These players include ABB (Switzerland), Schneider (France), Rockwell Automation (US), Yokogawa (Japan), Honeywell (US), Siemens (Germany), Larsen & Toubro (India), Mitsubishi (Japan), Emerson (US), Open system International (US), Advanced Control System (US), and Bentek Systems (Canada). These players adopted various strategies such as new product launches, contracts & agreements, and investments and expansions, to increase their global presence and market share.
- Published: January 2018
- Price: $ 4950
- TOC Available:
-
Dark Analytics Market by Component (Solutions, Services), Deployment Mode (Cloud, On-premises), Business Application (Marketing, Operations, Finance, Human Resources), Vertical (BFSI, Healthcare), and Region - Global Forecast to 2023
The dark analytics market is expected to grow from USD 278.3 million in 2018 to USD 867.7 million by 2023, at a CAGR of 25.5% from 2018 to 2023. The dark analytics market is projected to witness significant growth during the forecast period, majorly driven by the rapid increase in data generated by organizations, the adoption of artificial intelligence, and machine learning technologies for dark data analysis, and increase in the deployment of dark analytics solutions. Increasing investments in dark analytics technology by SMEs is one of the opportunities for growth in the dark analytics market. Dark analytics helps organizations in managing campaigns, making quick decisions, analyzing markets, and deriving customer insights. Dark analytics empowers the decision-making process of SMEs and enable them to easily identify existing and future business risks. The major vendors covered in the dark analytics market include IBM (US), SAP (Germany), Amazon Web Services (US), Micro Focus (UK), Dell EMC (US), Microsoft (US), AvePoint (US), Teradata (US), Symantec (US), Datameer (US), IRI (US), SAS (US), Commvault (US), Veritas (US), Cohesity (US), Datumize (Spain), SynerScope (Netherlands), Komprise (US), Lattice (US), Quantta Analytics (India), Zoomdata (US), Formcept (India), Globanet (US), Esdebe Consultancy (UK), and Levi, Ray & Shoup (US).
- Published: July 2018
- Price: $ 4950
- TOC Available:
-
Probiotic Ingredients Market by Application (Functional Foods & Beverages, Pharmaceuticals, and Animal Nutrition), Source (Bacteria and Yeast), Form (Dry and Liquid), End User (Human and Animal), and Region - Global Forecast to 2023
The probiotic ingredients market is projected to grow from USD 268 million in 2018 to USD 402 million by 2023, at a compound annual growth rate (CAGR) of 8.5% during the forecast period. The increasing demand for dietary supplements in the pharmaceuticals, cosmetics, and personal care industries is projected to drive the market for probiotics, which in turn, is projected to drive the market growth for probiotic ingredients.
- Published: December 2018
- Price: $ 4950
- TOC Available:
-
Data Lake Market by Component, Deployment Mode, Organization Size, Business Function (Marketing, Operations, and Human Resources), Industry Vertical (BFSI, Healthcare and Life Sciences, Manufacturing), and Region - Global Forecast to 2024
The data lake market is expected to grow from USD 7.9 billion in 2019 to USD 20.1 billion by 2024, at a compound annual growth rate (CAGR) of 20.6% during the forecast period.Major vendors in the global data lake market include Microsoft (US), Teradata (US), Oracle (US), Cloudera (US), AWS (US), IBM (US), Informatica (US), SAS Institute (US), Zaloni (US), Koverse (US), HPE (US), Cazena (US), Google (US), Infoworks.io (US), Snowflake (US), and Dremio (US). These vendors have adopted various organic and inorganic growth strategies, such as new product launches, partnerships and collaborations, and mergers and acquisitions, to expand their presence in the global data lake market.
- Published: January 2020
- Price: $ 4950
- TOC Available:
-
North America Human Microbiome Market By Drug & Supplement (Drugs, Probiotics, Prebiotics), Disease (Infectious, Gastrointestinal, Endocrine & Metabolic Diseases), Type (BCT/FMT, LBP), End User (Hospitals, Clinics, Long-term Care) - Forecast to 2031
North America Human Microbiome market, valued at US$0.43 billion in 2024, stood at US$0.78 billion in 2025 and is projected to advance at a resilient CAGR of 32.2% from 2025 to 2031, culminating in a forecasted valuation of US$4.15 billion by the end of the period. New startups in the US and Canada are driving innovation across microbiome therapeutics and diagnostics.
- Published: December 2025
- Price: $ 4950
- TOC Available:
-
North America Probiotics Market by Product Type (Functional Food & Beverages, Dietary Supplements, and Feed), Ingredient (Bacteria and Yeast), End User (Human and Animal), Distribution Channel, and Region - Forecast to 2030
The North America probiotics market is estimated to be USD 14.78 billion in 2025 and is projected to reach USD 21.92 billion by 2030, at a CAGR of 8.2% from 2025 to 2030. The Key ADM (US), Probi USA Inc. (US), Danone North America Public Benefit Corporation (US), International Flavors & Fragrances Inc. (US), Nestle USA (US), Lifeway Foods, Inc. (US), Lactalis American Group, Inc. (US), Kerry Group plc. (Ireland), Now Foods (US), Nature’s Bounty (US), Renewlife (US), Garden of Life (US), Jarrow Formulas, Inc. (US), Kevita (US), and Chobani, LLC. (US).
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Human Microbiome Manufacturing Services Market by Type (Fermentation & Downstream Processing, Strain Development & Optimization), Disease (Infectious, Gastrointestinal, Endocrine & Metabolic Disease) - Global Forecast to 2031
The global Human Microbiome Manufacturing Services market, valued at US$0.09 billion in 2024, stood at US$0.11 billion in 2025 and is projected to advance at a resilient CAGR of 16.7% from 2025 to 2031, culminating in a forecasted valuation of US$0.27 billion by the end of the period. Growing demand for specialized capabilities, such as anaerobic fermentation, microbial process scale-up, formulation, and fill-finish, is fueling broader adoption of human microbiome manufacturing services.
- Published: December 2025
- Price: $ 4950
- TOC Available:
-
Human Microbiome Drugs Market by Type (Live Biotherapeutic Products, Fecal Microbiota-derived Therapeutics), Disease (Gastrointestinal, Infectious), End User (Hospitals, Clinics, Long-term Care) - Global Forecast to 2031
The human microbiome drugs market, valued at US$0.09 billion in 2024, stood at US$0.35 billion in 2025 and is projected to advance at a resilient CAGR of 35.2% from 2025 to 2031, culminating in a forecasted valuation of US$2.13 billion by the end of the period. The human microbiome drugs market is growing, driven by the increasing clinical success of live biotherapeutic products, rising prevalence of chronic and recurrent diseases, and expanding therapeutic applications beyond gastrointestinal disorders into metabolic, immune, and neurological conditions.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Probiotics Market Report by Product Type (Functional Food & Beverages (FnB), Dietary Supplements, and Feed), Ingredient (Bacteria and Yeast), End User (Human and Animal), Distribution Channel and Region - Global Forecast to 2029
According to MarketsandMarkets, the global Probiotics market size is projected to reach USD 105.7 billion by 2029, recording a CAGR of 8.2% during the forecast period. Key players in this market include Probi (Sweden), Nestlé (Switzerland), ADM (US), Danone (France), International Flavors & Fragrances Inc. (US), Yakult Honsha Co., Ltd. (Japan), BioGaia (Sweden), MORINAGA MILK INDUSTRY CO., LTD. (Japan), Meiji Holdings Co., Ltd. (Japan), Lifeway Foods, Inc. (US), Adisseo (France), Winclove Probiotics (US), AB-Biotics, S.A. (Belgium), Apsen Farmacêutica (Brazil), and Lallemand (Canada).
- Published: March 2024
- Price: $ 4950
- TOC Available:
Records 31 to 40 of 50
